版本:
中国

BRIEF-Merck KGaA says still plan to apply for avelumab approval this year

Oct 13 Merck KGaA

* Says still plan to apply for marketing authorization in Europe, U.S. for avelumab against merkel cell carcinoma this year - CEO in media call Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐